MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/1381612824666180116100310

Медицинская библиотека · Current pharmaceutical design · 2018

The Role of Colchicine in the Prevention of Cerebrovascular Ischemia.

Tsivgoulis Georgios, Katsanos Aristeidis H, Giannopoulos Georgios, Panagopoulou Vasiliki, Jatuzis Dalius, Lemmens Robin, Deftereos Spyridon, Kelly Peter J

СтатьяПоддержка исследования: вне правительства СШАОбзорПеревод пока не подготовлен

Аннотация

INTRODUCTION

Despite the proven efficacy of anti-thrombotic, lipid-lowering, anti-hypertensive therapies and lifestyle modification changes for secondary ischemic stroke prevention, the risk of recurrent stroke, coronary events and vascular death remains substantial even for patients treated with high rates of established secondary preventive medications.

METHODS

In the present review, we summarize available literature data on the association between systemic inflammation and symptomatic atherosclerosis including recurrent cerebral ischemia. We also highlight the potential role of colchicine in the suppression of atherosclerosis-induced inflammation, plaque stabilization and thromboembolism prevention.

RESULTS

Accumulating evidence suggests that inflammation is of key importance in the pathophysiology of atherosclerotic plaque de-stabilization and thromboembolism, with inflammatory cells being involved in all stages of atherosclerosis development. Therefore, anti-inflammatory therapies targeting the atherosclerotic plaque inflammation may be important contributors in plaque stabilization and in the prevention of thromboembolic events. Colchicine is known to have multiple anti-inflammatory properties including inhibition of microtubule polymerization, leading to reduced secretion in monocyte-macrophages. Currently the randomized controlled CONVINCE trial is enrolling stroke patients to evaluate the effect of a daily low-dose of colchicine in reducing the rate of recurrent stroke and major vascular events.

CONCLUSION

Inflammatory pathways seem to be key mediators in the development of atherosclerotic process, atheromatous plaque destabilization and thromboembolism. Colchicine as a novel therapeutic agent could be a safe and effective inhibitor of the inflammation cascade in patients with extra- or intracranial atherosclerosis or arteriolosclerosis, resulting in reduced vascular events.

Для цитирования: Tsivgoulis Georgios, Katsanos Aristeidis H, Giannopoulos Georgios, Panagopoulou Vasiliki, Jatuzis Dalius, Lemmens Robin, Deftereos Spyridon, Kelly Peter J. The Role of Colchicine in the Prevention of Cerebrovascular Ischemia.. Current pharmaceutical design. 2018. DOI: 10.2174/1381612824666180116100310.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.